From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
Median Age, year-old (range)
50.5 (34–62)
Performance status, n (%)
0
13
1
17
2
FIGO stage
IIa2
3
IIb
20
IIIb
7
Histology
Squamous cell carcinoma
30
Not Squamous cell carcinoma
Grade
NC*
5
4